Literature DB >> 24930043

Comparison between transthoracic and transesophageal echocardiography in screening for infective endocarditis in patients with Staphylococcus aureus bacteremia.

D Wong1, Y Keynan, E Rubinstein.   

Abstract

Echocardiography is an important diagnostic tool in evaluating a patient with Staphylococcus aureus bacteremia (SAB) for diagnosing infective endocarditis (IE). We sought to compare the utility of transthoracic echocardiography (TTE) with transesophageal echocardiography (TEE) in screening for IE in patients with SAB. We performed a retrospective chart review of 285 adult patients from two tertiary care hospitals with at least one positive blood culture for S. aureus between 2010 and 2012. Patients who underwent echocardiography were divided into two groups: TTE (screened with TTE only) and TEE (screened with both TTE and TEE). The demographic factors and clinical outcomes were compared between the groups. Of the 285 charts reviewed, 213 (74.7 %) patients were screened with echocardiography: 183 (85.9 %) were screened with TTE alone and 30 (14.1 %) were screened with both TTE and TEE. TEE disclosed more cases of definite IE than TTE (8 [26.7 %] vs. 22 [12.0 %], p = 0.046). The TEE group had higher mortality than the TTE group (15 [50.0 %] vs. 43 [23.5 %], p = 0.004). In patients with definite IE, mortality was higher in the TEE group than in the TTE group (6 [75.0 %] vs. 6 [27.3 %], p = 0.034). TEE discovered additional findings that were missed by TTE in 36.7 % of cases and refuted the findings of TTE in 13.3 % of cases. We do not support the routine use of TEE in patients with uncomplicated SAB. High-risk patients in which IE is a serious consideration should undergo investigation with TEE.

Entities:  

Mesh:

Year:  2014        PMID: 24930043     DOI: 10.1007/s10096-014-2178-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients.

Authors:  V G Fowler; J Li; G R Corey; J Boley; K A Marr; A K Gopal; L K Kong; G Gottlieb; C L Donovan; D J Sexton; T Ryan
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

3.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

4.  Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia.

Authors:  Achim J Kaasch; Vance G Fowler; Siegbert Rieg; Gabriele Peyerl-Hoffmann; Hanna Birkholz; Martin Hellmich; Winfried V Kern; Harald Seifert
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

5.  Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis.

Authors:  A Incani; C Hair; P Purnell; D P O'Brien; A C Cheng; A Appelbe; E Athan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-17       Impact factor: 3.267

6.  Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.

Authors:  Rasmus V Rasmussen; Ulla Høst; Magnus Arpi; Christian Hassager; Helle K Johansen; Eva Korup; Henrik C Schønheyder; Jens Berning; Sabine Gill; Flemming S Rosenvinge; Vance G Fowler; Jacob E Møller; Robert L Skov; Carsten T Larsen; Thomas F Hansen; Shan Mard; Jesper Smit; Paal S Andersen; Niels E Bruun
Journal:  Eur J Echocardiogr       Date:  2011-06

7.  Echocardiography predicts embolic events in infective endocarditis.

Authors:  G Di Salvo; G Habib; V Pergola; J F Avierinos; E Philip; J P Casalta; J M Vailloud; G Derumeaux; J Gouvernet; P Ambrosi; M Lambert; A Ferracci; D Raoult; R Luccioni
Journal:  J Am Coll Cardiol       Date:  2001-03-15       Impact factor: 24.094

8.  The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia.

Authors:  S J Van Hal; G Mathur; J Kelly; C Aronis; G B Cranney; P D Jones
Journal:  J Infect       Date:  2005-10       Impact factor: 6.072

9.  Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up.

Authors:  V G Fowler; L L Sanders; L K Kong; R S McClelland; G S Gottlieb; J Li; T Ryan; D J Sexton; G Roussakis; L J Harrell; G R Corey
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

10.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

View more
  1 in total

1.  Diagnosis of infective endocarditis using echocardiography.

Authors:  Xin-Chun Yuan; Ming Liu; Jia Hu; Xi Zeng; Ai-Yun Zhou; Li Chen
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.